Skip to content
10-Q

Quarterly Report

Guardian Pharmacy Services, Inc. GRDN

0001193125-26-209021

← back to feed
Filed
May 6, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow Q1 2026 · Mar 31, 2026 $6.06M
Operating Cash Flow Q1 2026 · Mar 31, 2025 $17.55M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $64.89M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $65.62M
Stockholders Equity Q1 2026 · Mar 31, 2026 $232.42M
Stockholders Equity Q1 2026 · Dec 31, 2025 $217.92M
Stockholders Equity Q1 2026 · Mar 31, 2025 $163.22M
Stockholders Equity Q1 2026 · Dec 31, 2024 $149.98M
Current Liabilities Q1 2026 · Mar 31, 2026 $160.54M
Current Liabilities Q1 2026 · Dec 31, 2025 $160.7M
Total Liabilities Q1 2026 · Mar 31, 2026 $194.52M
Total Liabilities Q1 2026 · Dec 31, 2025 $194.73M
Current Assets Q1 2026 · Mar 31, 2026 $235.18M
Current Assets Q1 2026 · Dec 31, 2025 $221.63M
Total Assets Q1 2026 · Mar 31, 2026 $426.94M
Total Assets Q1 2026 · Dec 31, 2025 $412.66M
Sga Expense Q1 2026 · Mar 31, 2026 $58.63M
Sga Expense Q1 2026 · Mar 31, 2025 $51.34M
Net Income Q1 2026 · Mar 31, 2026 $13.3M
Net Income Q1 2026 · Mar 31, 2025 $9.45M
Operating Income Q1 2026 · Mar 31, 2026 $17.68M
Operating Income Q1 2026 · Mar 31, 2025 $13.01M
Gross Profit Q1 2026 · Mar 31, 2026 $76.31M
Gross Profit Q1 2026 · Mar 31, 2025 $64.35M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $260.29M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $264.96M
Revenue Q1 2026 · Mar 31, 2026 $336.6M
Revenue Q1 2026 · Mar 31, 2025 $329.31M